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What Question Did This Investigation Aim to Answer?
In adult emergency department (ED) patients with suspected acute lower respiratory tract infection and uncertain appropriateness for antibiotic therapy, is a procalcitonin-guided protocol more effective than usual care at reducing antibiotic exposure within 30 days of enrollment?
What Study Design Did the Authors Choose?
Design: Prospective, interventional, randomized, parallel-assignment clinical trial. Only outcomes assessors were blinded to group assignment. Procalcitonin Antibiotic Consensus Trial (ProACT) ClinicalTrials.gov NCT02130986.
Setting: Fourteen hospitals and EDs in the United States with high adherence to quality measures for the treatment of pneumonia.
Population: A total of 1,656 adult ED patients with suspected lower respiratory tract infection of less than 28 days' duration to whom antibiotics had not been given, and for whom there was uncertainty in regard to the need for antibiotics.
Intervention: National antibiotic guidelines for lower respiratory tract infection were disseminated, along with a procalcitonin antibiotic prescribing guideline (Table) . In the intervention arm, procalcitonin levels were provided to treating clinicians at enrollment and, if patients were hospitalized, during their hospital stay.
Primary Outcomes: Total antibiotic-days within 30 days after enrollment Secondary Outcomes:
Adverse outcomes judged related to withholding antibiotics Prescription of antibiotics from the ED Antibiotic-days while patients were hospitalized and receipt of antibiotics within 30 days after enrollment
How Did the Authors Interpret the Results?
In the intention-to-treat analysis, antibiotic exposures were similar between the procalcitonin and usual care arms with the mean antibiotic-days 4.2 and 4.3 days, respectively. The difference was -0.05 day (95% confidence interval -0.6 to 0.5). Results of per-protocol, per-guideline, complete case, and missing-not-at-random analyses were consistent with these findings. An adverse event had occurred in 11.7% of patients in the procalcitonin arm compared with 13.1% for those in the usual care arm, a difference of -1.5% (95% confidence interval -4.6% to 1.7%), which did not exceed the authors' prespecified noninferiority margin. Across remaining secondary outcomes, small absolute differences were not reliably significant. Adherence to disseminated procalcitonin antibiotic prescribing recommendations was 64.8% at all points during the protocol period. In this large, pragmatic trial, incorporating procalcitonin into clinical practice did not robustly reduce antibiotic prescribing. These results are in contrast with the bulk of related published literature, 1 which typically demonstrates small absolute reductions in antibiotic-days, absent any increase in adverse safety events. Although these data are an important contribution to the evidence base describing the clinical application of procalcitonin assays, this null finding does not definitively determine its disutility.
DISCUSSION POINTS
1. Discuss the important differences between an intentionto-treat and per-protocol analysis. Why did these investigators report the results of both analyses? The distinction between intention-to-treat and perprotocol analyses is important. In an intention-to-treat analysis, all enrolled patients are included in subsequent statistical comparisons. This ostensibly reduces potential bias relating to study participants who were unable to complete the protocol. For example, patients in a pharmaceutical trial who discontinue the study protocol may be doing so because of adverse effects or inadequate treatment response, distorting the final results. In this trial, protocol adherence for the procalcitonin arm directly affected the primary outcome and was unfortunately much lower than that of most previous trials. The per-protocol analysis, however, demonstrated similar results. Most protocol deviations related to inappropriate antibiotic prescribing against guideline recommendations, leaving behind a per-protocol cohort for whom antibiotic use was generally recommended, naturally limiting the possibility of observing a difference. 5, 6 Mitigation of the potential biases introduced by professional and financial conflicts of interest is a complex topic. Generally speaking, multiple systematic reviews have identified trial sponsorship as contributing to publication bias in the direction of favorable results. These findings, in part, provided the impetus for requirements for clinical trial registration. The purpose of registration is manifold and includes maintaining a record of trials to reduce nonpublication of null findings and to require researchers to prospectively declare their methods and outcomes before conducting the trial. Whether trial registration has improved the integrity of medical research is a matter for debate because this is still generally a passive mechanism for encouraging publication, it still requires proactive oversight to verify outcomes, and scientific methods have not changed. In addition, there are many other strategies used by sponsors to bias trial designs, including exclusion criteria, surrogate endpoints, and straw man comparisons. This specific trial is not devoid of declarations of possible relevant conflict of interest, as described in the self-reported disclosure forms available on the New England Journal of Medicine Web site (https://www.nejm.org). BioMérieux provided the assay and laboratory training, whereas some authors reported professional or financial relationships with the pharmaceutical industry; however, the authors stated that BioMérieux had no other role in the trial, including the data analysis. Investigators were blinded to all data collection until data lock, and outcomes assessors were blinded to group assignment. It is not specifically mentioned here, but some trials will also further perform blinded analyses and article drafting before unmasking group assignments; this can further reduce the influence of unrecognized professional or financial biases toward results reporting. 
What Question Did This Investigation Aim to Answer?
In adult ED patients undergoing emergency intubation and possessing at least one characteristic of a difficult airway, does the empiric use of a bougie improve first-pass success?
What Study Design Did the Authors Choose?
Design: Prospective, randomized, controlled trial. Setting: Single urban academic ED. Population: A total of 757 adult ED patients requiring emergency intubation in which the treating physician used a standard geometry blade on the first attempt. Of these patients, 380 were determined to have at least one difficult airway characteristic (defined as body fluid[s] obscuring the laryngeal view, airway obstruction or edema, obesity, short neck, small mandible, large tongue, facial trauma, or cervical spine immobilization).
Intervention: During the first attempt, the operator endeavored to pass a bougie into the trachea. If the attempt was successful, an assistant loaded the endotracheal tube over the bougie and the operator guided it into the trachea while keeping the laryngoscope in the mouth.
Control: During the first attempt, the operator used an endotracheal tube with stylet with a straight-to-cuff-shape 25-to 35-degree angle at the cuff.
Primary Outcomes: First-pass success in patients with at least one difficult airway characteristic Secondary Outcomes:
First-pass success in the larger cohort of ED patients requiring intubation First-pass success in cervical in-line immobilization First-pass success in obese patients First-pass success in patients with incomplete glottic views on laryngoscopy
How Did the Authors Interpret the Results?
For patients randomized to the bougie-first approach, the authors found a 14% absolute increase in their primary outcome, the rate of first-pass success in patients with at least one difficult airway characteristic. A similar 11% absolute benefit in favor of the bougie-first method was noted in the entire 757-patient cohort. Even in the subset of patients who were not predicted to have a difficult airway, a 7% absolute increase in the rate of first-pass success was observed. The bougie also proved superior to the traditional endotracheal tube and stylet in patients requiring cervical in-line immobilization (100% versus 78%), obese patients (96% versus 75%), and patients with incomplete glottic views on laryngoscopy corresponding to Cormack-Lehane grades 2 to 4 (97% versus 60%).
How Might This Study Affect Your Clinical Practice in the ED?
Although this trial has a number of methodological limitations, Driver et al present a strong argument in favor of a bougie-first approach for ED patients requiring intubation. The strength of the authors' conclusions lies in the consistency with which the bougie demonstrated its efficacy. Not only was the bougie superior to the more traditional stylet-based approach for intubations predicted to be difficult by the emergency physician but also it improved first-pass success in patients in whom a difficult airway was not suspected.
DISCUSSION POINTS
1. Define external validity. What aspects of this trial's design harm its external validity? External validity refers to how well the results may be generalized to the greater population. The trial by Driver et al was performed at a single ED in which the bougie was commonly deployed early in the intubation rather than as a rescue device when more traditional equipment had failed. How this applies to other facilities whose providers are less familiar with the bougie and its nuances is unclear. How would these results translate to an ED whose providers are less comfortable with using the bougie? Similarly, would the endotracheal tubeþstylet group have performed as poorly in an environment in which this was the traditional method used on first attempt? Additionally, the majority of these intubations were performed by resident physicians in training, and the first-pass rate was surprisingly low. Would the bougie-first method appear superior when applied to a group of experienced physicians who more readily recognize when to ask for a bougie rather than the standard endotracheal tubeþstylet? The answers to these questions are unclear, and thus we are incapable of freely generalizing these results to all patients requiring emergency intubation across all EDs.
Therefore, it is not clear whether these results can be generalized to all patients requiring intubation in the ED setting. The results presented by Driver et al may very well be internally valid, meaning the difference observed between the 2 groups represents the true difference because of the bougie's efficacy rather than because of sampling error or bias. In contrast, its external validity is unclear. Authorship: All authors attest to meeting the four ICMJE.org authorship criteria: (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
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